| Mrs Chloe Hinson Martin, FNP-BC | |
|
355 S Georgetown Hwy, Johnsonville, SC 29555-8083 | |
| (843) 380-2000 | |
| (843) 380-2014 |
| Full Name | Mrs Chloe Hinson Martin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 355 S Georgetown Hwy, Johnsonville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467992511 | NPI | - | NPPES |
| NP4518 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20711 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Kingstree, SC | Home health agency |
| Amedisys Home Health Of Georgetown | Georgetown, SC | Home health agency |
| Mcleod Health Clarendon | Manning, SC | Hospital |
| Mcleod Regional Medical Center-pee Dee | Florence, SC | Hospital |
| Musc Health Florence Medical Center | Florence, SC | Hospital |
| Tidelands Georgetown Memorial Hospital | Georgetown, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcleod Health Clarendon | 0840582656 | 73 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Seniors in the U.S. are overwhelmingly satisfied with their current Medicare coverage, according to a survey released today by Silverlink Communications and Suffolk University in Boston. Of the more than 2,600 Medicare beneficiaries surveyed, more than 94% indicate that they are satisfied with their coverage, with just 6% expressing dissatisfaction.
House Republican leaders on Friday evening released legislation "designed to fund the rest of the fiscal year, which includes $100 billion in discretionary spending cuts compared with President Obama's fiscal 2011 budget request," National Journal reports.
Tivantinib is an effective second-line therapy for hepatocellular carcinoma patients whose tumors exhibit high MET receptor tyrosine kinase expression, indicate phase II study results.
› Verified 7 days ago
| Entity Name | Lower Florence County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902903222 PECOS PAC ID: 6608802152 Enrollment ID: O20050808000493 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Seniors in the U.S. are overwhelmingly satisfied with their current Medicare coverage, according to a survey released today by Silverlink Communications and Suffolk University in Boston. Of the more than 2,600 Medicare beneficiaries surveyed, more than 94% indicate that they are satisfied with their coverage, with just 6% expressing dissatisfaction.
House Republican leaders on Friday evening released legislation "designed to fund the rest of the fiscal year, which includes $100 billion in discretionary spending cuts compared with President Obama's fiscal 2011 budget request," National Journal reports.
Tivantinib is an effective second-line therapy for hepatocellular carcinoma patients whose tumors exhibit high MET receptor tyrosine kinase expression, indicate phase II study results.
› Verified 7 days ago
| Entity Name | Mcleod Health Clarendon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508218793 PECOS PAC ID: 0840582656 Enrollment ID: O20160915000930 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Seniors in the U.S. are overwhelmingly satisfied with their current Medicare coverage, according to a survey released today by Silverlink Communications and Suffolk University in Boston. Of the more than 2,600 Medicare beneficiaries surveyed, more than 94% indicate that they are satisfied with their coverage, with just 6% expressing dissatisfaction.
House Republican leaders on Friday evening released legislation "designed to fund the rest of the fiscal year, which includes $100 billion in discretionary spending cuts compared with President Obama's fiscal 2011 budget request," National Journal reports.
Tivantinib is an effective second-line therapy for hepatocellular carcinoma patients whose tumors exhibit high MET receptor tyrosine kinase expression, indicate phase II study results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Chloe Hinson Martin, FNP-BC Po Box 3239, Florence, SC 29502-3239 Ph: (843) 380-2000 | Mrs Chloe Hinson Martin, FNP-BC 355 S Georgetown Hwy, Johnsonville, SC 29555-8083 Ph: (843) 380-2000 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Seniors in the U.S. are overwhelmingly satisfied with their current Medicare coverage, according to a survey released today by Silverlink Communications and Suffolk University in Boston. Of the more than 2,600 Medicare beneficiaries surveyed, more than 94% indicate that they are satisfied with their coverage, with just 6% expressing dissatisfaction.
House Republican leaders on Friday evening released legislation "designed to fund the rest of the fiscal year, which includes $100 billion in discretionary spending cuts compared with President Obama's fiscal 2011 budget request," National Journal reports.
Tivantinib is an effective second-line therapy for hepatocellular carcinoma patients whose tumors exhibit high MET receptor tyrosine kinase expression, indicate phase II study results.
› Verified 7 days ago
Katelyn Hanna Rogers, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 355 S Georgetown Hwy, Johnsonville, SC 29555 Phone: 843-380-2000 Fax: 843-380-2014 | |
Mrs. Samantha C Willard, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 355 S Georgetown Hwy, Johnsonville, SC 29555 Phone: 843-380-2000 Fax: 843-380-2014 |